Ronit Simantov
Ronit Simantov holds the position of Chief Medical & Scientific Officer at Gamida Cell Ltd. She is also on the board of TempestTx, Inc. and Tempest Therapeutics, Inc.
She previously occupied the position of Vice President-Oncology Global Medical Affairs at Pfizer Inc., Vice President-Clinical Research at OSI Pharmaceuticals, Inc., Vice President-Medical Development at CuraGen Corp. and Oncology Director at Bayer HealthCare Pharmaceuticals, Inc.
She received an undergraduate degree from The Johns Hopkins University and a doctorate from New York University School of Medicine.
Transactions
Date
Transaction
Value
| 02/08/2023 | 58,100 | Award at $0 per share. | 0 |
